Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies

Br J Haematol. 2020 May;189(4):e119-e122. doi: 10.1111/bjh.16543. Epub 2020 Feb 27.

Elise Fournier¹, Camille Debord², Valérie Soenen¹, Nathalie Trillot³, Fanny Gonzales⁴, Véronique Tintiller³, Louis Terriou⁵, Coralie Derrieux¹, Wadih Abou Chahla⁴, Camille Paris³, Céline Berthon^{6

7}, Thomas Boyer^{1

8}, Anne Lambilliotte⁴, Pierre Boisseau⁹, Soraya Wuillème², Marc Fouassier^{2

10}, Sophie Susen^{3

11}, Claude Preudhomme^{1

7}, Nicolas Duployez^{1

7}

¹ Laboratory of Haematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.
² Laboratory of Haematology, CHU Nantes, Nantes, France.
³ Department of Haemostasis and Transfusion, CHU Lille, Lille, France.
⁴ Department of Paediatric Haematology, CHU Lille, Lille, France.
⁵ Department of Internal Medicine and Clinical Immunology, CHU Lille, Lille, France.
⁶ Department of Clinical Haematology, CHU Lille, Lille, France.
⁷ CNRS, INSERM, UMR 9020 - UMR-S 1277, University of Lille, Lille, France.
⁸ Laboratory of Haematology, CHU Amiens-Picardie, Amiens, France.
⁹ Department of Clinical Genetics, CHU Nantes, Nantes, France.
¹⁰ Haemophilia Center, CHU Nantes, Nantes, France.
¹¹ INSERM, UMR 1011, Institut Pasteur de Lille, University of Lille, Lille, France.

No abstract available

Keywords: ANKRD26; ETV6; RUNX1; germline predisposition; thrombocytopenia.

Publication types